3D 打印藥品全球市場規模研究，按技術，按應用，按最終用途，按地區預測 2022-2028

2021 年全球 3D 打印藥品市場價值約為 7202 萬美元，預計在 2022-2028 年的預測期內以超過 15.30% 的健康增長率增長。

3D 打印藥物是通過 3D 打印過程創建的處方，旨在為個人提供安全、有效和量身定制的藥物。這些藥物不需要整個吞服，因為它們的一體式多孔結構很容易在口腔中分散。這使生產商可以輕鬆修改不同藥物的大小、形狀、外觀和分佈動力學。由於對個性化醫療的需求不斷增長，以及支持 3D 打印的研發活動迅速擴大，市場正在蓬勃發展。這項技術通過實現個性化醫療為改善患者護理創造了有希望的機會。為了使藥物更安全、更有效，自 2015 年美國個性化醫學倡議成立以來，製藥研究公司也一直在尋求開發更專業的治療方法。因此，預計未來幾年對 3D 打印藥品的需求將會增長。增加運營商對生產先進有效的 3D 打印藥品的投資以及 3D 打印技術的突破預計將在預測期內推動市場增長。例如，CurfiyLabs 和 Natural Machines 於 2022 年 3 月合作，根據患者的個體需求生產這些藥物。希望這將使藥店和醫院能夠更快地收到藥品。然而，這些藥物的副作用、使用 3D 打印機開發非法藥物以及政府對 3D 打印機產品缺乏監管等都是阻礙市場擴張的因素。另一方面，隨著新興國家醫療保健系統和技術的突破，人們對這些藥物的快速溶解等益處的普遍認識有望為市場擴張創造廣闊的潛力。

全球 3D 打印藥品市場研究考慮的主要地區是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。亞太地區在 3D 打印藥物市場擁有最大的市場份額，預計在預測期內將以健康的複合年增長率增長。醫療基礎設施的快速發展和醫療研發投資的增加預計將推動亞太地區 3D 打印藥品市場的增長。由於歐洲人的健康意識不斷增強，預計歐洲地區在預測期內也將實現令人滿意的增長。

本報告中包含的主要市場參與者是：

• Extend Biosciences
• BioDuro
• Affinity Therapeutics
• Osmotica Pharmaceuticals
• Aprecia Pharmaceuticals LLC
• GlaxoSmithKline Plc
• FabRx Ltd
• Hewlett Packard Caribe
• Merck

本研究的目的是確定近年來各個細分市場和國家/地區的市場規模，並預測未來 8 年的價值。該報告旨在包括按地區和國家研究的行業的定性和定量方面。此外，它還提供了有關關鍵方面的詳細信息，例如定義市場未來增長的驅動因素和挑戰。此外，報告還應詳細分析主要參與者的競爭格局和產品供應，以及微觀市場中可供利益相關者投資的機會。市場的詳細細分和子細分如下所述。

按技術

噴墨打印

熔融增材製造

立體光刻

ZipDose 技術

按應用程序

骨科

神經

牙科

雜項

按最終用戶

醫院/診所

研究所

雜項

按地區

北美

美國

加拿大

歐洲

英國

德國

法國

西班牙

意大利

其他歐洲

亞太地區

中國

印度

日本

澳大利亞

韓國

其他亞太地區

拉丁美洲

巴西

墨西哥

世界其他地方

此外，本研究考慮的年份是：

實際年份 - 2018 年、2019 年、2020 年

2021 年基準年

預測期 - 2022 年 至 2028 年

本報告的目標受眾是全球 3D 打印藥品市場。

主要諮詢公司和顧問

大公司、中型公司、中小企業

風險投資

增值經銷商 (VAR)

第三方知識提供者

投資銀行家

投資者

內容

第 1 章執行摘要

• 市場快照
• 2020-2028 年全球市場細分的估計和預測
  • 2020-2028 年按地區分列的 3D 打印藥品市場
  • 3D 打印藥品市場：按技術，2020-2028
  • 2020-2028 年按應用分列的 3D 打印藥品市場
  • 3D 打印藥品市場：按最終用途分類（2020-2028 年）
• 主要趨勢
• 調查方法
• 調查先決條件

第 2 章 3D 打印藥劑的全球市場定義和範圍

• 調查目的
• 市場定義和範圍
  • 調查範圍
  • 工業發展
• 調查年份
• 貨幣兌換率

第 3 章全球 3D 打印藥品市場動態

• 3D 打印藥品市場影響分析（2020-2028）
  • 市場驅動力
    • 3D 打印在醫療行業的使用率不斷提高
    • 擴大個性化藥物的採用
  • 市場挑戰
    • 政府對 3D 打印產品缺乏監管
  • 市場機會
    • 對速溶片的高需求

第 4 章 3D 打印藥品全球市場行業分析

• 波特的 5 力模型
  • 供應商的議價能力
  • 買家的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的敵對關係
  • 到波特的 5 力模型 未來主義方法（2018-2028）
• PEST 分析
  • 政治
  • 經濟
  • 社交
  • 技術
• 招商引資模式
• 分析師的結論和建議
• 熱門投資機會
• 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

• 評估 COVID-19 對行業的整體影響
• COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球 3D 打印藥品市場：按技術分類

• 市場快照
• 按技術分列的 3D 打印藥品全球市場 , 按性能, 潛力分析
• 2018-2028 年全球 3D 打印藥品市場、技術估計和預測
• 3D 打印藥品市場，按細分市場分析
  • 噴墨打印
  • 融合增材製造
  • 立體光刻
  • ZipDose 技術 諾學

第 7 章全球 3D 打印藥品市場：按應用分類

• 市場快照
• 3D 打印藥劑的全球市場：按應用分列的性能和潛力分析
• 2018-2028 年全球 3D 打印藥劑市場、估計和預測（按應用）
• 3D 繪圖 皮棉製藥市場，細分分析
  • 骨科
  • 神經科
  • 牙科
  • 其他

第 8 章全球 3D 打印藥品市場：按最終用途分類

• 市場快照
• 3D 打印藥劑的全球市場：按最終用途劃分的實際情況 性能/潛力分析
• 2018-2028 年全球 3D 打印藥品市場、估計和預測（按最終用途）
• 3D 打印藥品市場，細分分析
  • 醫院和診所
  • 研究所
  • 其他

第 9 章 3D 打印藥物代理的全球市場：區域 區域分析

• 3D 打印藥物代理的全球市場，區域市場快照
• 北美
  • 美國
    • 2018-2028 年按技術劃分的估計和預測
    • 按應用劃分的估計和預測，2018-2028
    • 按最終用途劃分的估計和預測，2018 年 2028-2028
  • 加拿大
• 歐洲 3D 打印藥品市場概況
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 意大利
  • 其他歐洲地區
• 亞太 3D 打印藥品市場概覽
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 其他亞太地區
• 拉丁美洲 3D 打印藥品市場概況
  • 巴西
  • 墨西哥
• 世界其他地區

第十章比賽 匹配信息

• 頂級市場策略
• 公司簡介
  • 擴展生物科學
    • 主要信息
    • 概覽
    • 財務（取決於數據可用性）
    • 應用概覽
    • 近期發展
  • Bioduro
  • 親和力 療法
  • Osmotica Pharmaceuticals
  • Aprecia Pharmaceuticals LLC
  • GlaxoSmithKline Plc
  • FabRx Ltd
  • Hewlett Packard Caribe
  • Merck

第 11 章研究過程

• 研究過程
  • 數據挖掘 G
  • 分析
  • 市場估算
  • 驗證
  • 出版
• 調查屬性
• 調查先決條件

Global 3D Printed Drugs Market is valued at approximately USD 72.02 million in 2021 and is anticipated to grow with a healthy growth rate of more than 15.30% over the forecast period 2022-2028. 3D printed drugs are prescriptions created with the 3D printing process to provide individuals with safe and effective tailored medications. These drugs don't need to be swallowed whole because of the unitary porous architecture that makes it simple for them to scatter in the mouth. It makes it simple for producers to alter the size, shape, appearance, and rate of distribution of a variety of medications. The market is booming as a result of rising demand for personalized drugs and rapidly expanding R&D activities supporting 3D printing. By producing personalized medical therapies, this technology creates promising opportunities for improving patient care. To make pharmaceuticals safer and more effective, pharmaceutical research companies have also been looking into the development of more specialised remedies since the establishment of the United States Personalized Medicine Initiative in 2015. As a result, demand for 3D-printed drugs is expected to increase in the coming years.Increased investments by operating players in the production of advanced and effective 3D printed pharmaceuticals, as well as breakthroughs in 3D printing technology, are expected to drive market growth over the forecast period. CurfiyLabs and Natural Machines, for example, collaborated in March 2022 on the production of these medicines based on the needs of individual patients. This is expected to allow pharmacies and hospitals to receive medications more quickly. However, the adverse effects of these drugs, the development of illicit drugs using 3D printing and the absence of government restrictions for 3D printed goods are two factors that are limiting market expansion. On the other hand, growing public knowledge of the advantages of these medications, such as their rapid solubility, along with breakthroughs in healthcare systems and technology in emerging nations, are anticipated to create a wide range of potential for market expansion.

The key regions considered for the global 3D Printed Drugs market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific has the largest market share in the 3D printed drugs market and is expected to grow at a healthy CAGR during the forecast period. Rapid development of healthcare infrastructure and increased investment in healthcare research and development are expected to drive the growth of the Asia Pacific 3D printed drugs market. The Europe region is also expected to grow satisfactorily during the forecast period, owing to rising health consciousness among Europeans.

Major market players included in this report are:

Extend Biosciences

BioDuro

Affinity Therapeutics

Osmotica Pharmaceuticals

Aprecia Pharmaceuticals LLC

GlaxoSmithKline Plc

FabRx Ltd

Hewlett Packard Caribe

Merck

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

ByTechnology:

Inkjet Printing

Fused Deposition Modeling

Stereolithography

ZipDose Technology

By Application:

Orthopedic

Neurology

Dental

Others

By End-use:

Hospitals & clinics

Research Laboratories

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global 3D Printed Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
  • 1.2.1. 3D Printed Drugs Market, by Region, 2020-2028 (USD Million)
  • 1.2.2. 3D Printed Drugs Market, by Technology,2020-2028 (USD Million)
  • 1.2.3. 3D Printed Drugs Market, by Application,2020-2028 (USD Million)
  • 1.2.4. 3D Printed Drugs Market, by End-use,2020-2028 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global 3D Printed Drugs Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global 3D Printed Drugs Market Dynamics

• 3.1. 3D Printed Drugs Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising Usage Of 3D Printing in The Medical Industries
    • 3.1.1.2. Increasing Adoption of Personalized Drugs
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack Of Government Regulations for 3D Printed Products
  • 3.1.3. Market Opportunities
    • 3.1.3.1. High Demand for Instantaneous Soluble Tablets

Chapter 4. Global 3D Printed Drugs Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global 3D Printed Drugs Market, by Technology

• 6.1. Market Snapshot
• 6.2. Global 3D Printed Drugs Market by Technology, Performance - Potential Analysis
• 6.3. Global 3D Printed Drugs Market Estimates & Forecasts by Technology,2018-2028 (USD Million)
• 6.4. 3D Printed Drugs Market, Sub Segment Analysis
  • 6.4.1. Inkjet Printing
  • 6.4.2. Fused Deposition Modeling
  • 6.4.3. Stereolithography
  • 6.4.4. ZipDose Technology

Chapter 7. Global 3D Printed Drugs Market, by Application

• 7.1. Market Snapshot
• 7.2. Global 3D Printed Drugs Market by Application, Performance - Potential Analysis
• 7.3. Global 3D Printed Drugs Market Estimates & Forecasts by Application,2018-2028 (USD Million)
• 7.4. 3D Printed Drugs Market, Sub Segment Analysis
  • 7.4.1. Orthopedic
  • 7.4.2. Neurology
  • 7.4.3. Dental
  • 7.4.4. Others

Chapter 8. Global 3D Printed Drugs Market, by End-use

• 8.1. Market Snapshot
• 8.2. Global 3D Printed Drugs Market by End-use, Performance - Potential Analysis
• 8.3. Global 3D Printed Drugs Market Estimates & Forecasts by End-use,2018-2028 (USD Million)
• 8.4. 3D Printed Drugs Market, Sub Segment Analysis
  • 8.4.1. Hospitals & clinics
  • 8.4.2. Research Laboratories
  • 8.4.3. Others

Chapter 9. Global 3D Printed Drugs Market, Regional Analysis

• 9.1. Global 3D Printed Drugs Market, Regional Market Snapshot
• 9.2. North America 3D Printed Drugs Market
  • 9.2.1. U.S. 3D Printed Drugs Market
    • 9.2.1.1. Technology breakdown estimates & forecasts, 2018-2028
    • 9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
    • 9.2.1.3. End-use breakdown estimates & forecasts, 2018-2028
  • 9.2.2. Canada3D Printed Drugs Market
• 9.3. Europe 3D Printed Drugs Market Snapshot
  • 9.3.1. U.K. 3D Printed Drugs Market
  • 9.3.2. Germany 3D Printed Drugs Market
  • 9.3.3. France 3D Printed Drugs Market
  • 9.3.4. Spain 3D Printed Drugs Market
  • 9.3.5. Italy 3D Printed Drugs Market
  • 9.3.6. Rest of Europe3D Printed Drugs Market
• 9.4. Asia-Pacific 3D Printed Drugs Market Snapshot
  • 9.4.1. China 3D Printed Drugs Market
  • 9.4.2. India 3D Printed Drugs Market
  • 9.4.3. Japan 3D Printed Drugs Market
  • 9.4.4. Australia 3D Printed Drugs Market
  • 9.4.5. South Korea 3D Printed Drugs Market
  • 9.4.6. Rest of Asia Pacific 3D Printed Drugs Market
• 9.5. Latin America 3D Printed Drugs Market Snapshot
  • 9.5.1. Brazil 3D Printed Drugs Market
  • 9.5.2. Mexico 3D Printed Drugs Market
• 9.6. Rest of The World 3D Printed Drugs Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Extend Biosciences
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Application Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Bioduro
  • 10.2.3. Affinity Therapeutics
  • 10.2.4. Osmotica Pharmaceuticals
  • 10.2.5. Aprecia Pharmaceuticals LLC
  • 10.2.6. GlaxoSmithKline Plc
  • 10.2.7. FabRx Ltd
  • 10.2.8. Hewlett Packard Caribe
  • 10.2.9. Merck

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global 3D Printed Drugs Market, report scope
• TABLE 2. Global 3D Printed Drugs Market estimates & forecasts by Region2018-2028 (USD Million)
• TABLE 3. Global 3D Printed Drugs Market estimates & forecasts by Technology 2018-2028 (USD Million)
• TABLE 4. Global 3D Printed Drugs Market estimates & forecasts by Application 2018-2028 (USD Million)
• TABLE 5. Global 3D Printed Drugs Market estimates & forecasts by End-use 2018-2028 (USD Million)
• TABLE 6. Global 3D Printed Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 7. Global 3D Printed Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 8. Global 3D Printed Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 9. Global 3D Printed Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 10. Global 3D Printed Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 11. Global 3D Printed Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 12. Global 3D Printed Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 13. Global 3D Printed Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 14. Global 3D Printed Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 15. Global 3D Printed Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 16. U.S. 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 17. U.S. 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 18. U.S. 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 19. Canada 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 20. Canada 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 21. Canada 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 22. UK3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 23. UK3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 24. UK3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 25. Germany 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 26. Germany 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 27. Germany 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 28. RoE3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 29. RoE3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 30. RoE3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 31. China 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 32. China 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 33. China 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 34. India 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 35. India 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 36. India 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 37. Japan 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 38. Japan 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 39. Japan 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 40. RoAPAC3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 41. RoAPAC3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 42. RoAPAC3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 43. Brazil 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 44. Brazil 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 45. Brazil 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 46. Mexico 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 47. Mexico 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 48. Mexico 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 49. RoLA3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 50. RoLA3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 51. RoLA3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 52. Row 3D Printed Drugs Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 53. Row 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 54. Row 3D Printed Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 55. List of secondary sources, used in the study of global 3D Printed Drugs Market
• TABLE 56. List of primary sources, used in the study of global 3D Printed Drugs Market
• TABLE 57. Years considered for the study
• TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

• FIG 1. Global 3D Printed Drugs Market, research methodology
• FIG 2. Global 3D Printed Drugs Market, market estimation techniques
• FIG 3. Global market size estimates & forecast methods
• FIG 4. Global 3D Printed Drugs Market, key trends 2021
• FIG 5. Global 3D Printed Drugs Market, growth prospects 2022-2028
• FIG 6. Global 3D Printed Drugs Market, porters 5 force model
• FIG 7. Global 3D Printed Drugs Market, pest analysis
• FIG 8. Global 3D Printed Drugs Market, value chain analysis
• FIG 9. Global 3D Printed Drugs Market by segment, 2018 & 2028 (USD Million)
• FIG 10. Global 3D Printed Drugs Market by segment, 2018 & 2028 (USD Million)
• FIG 11. Global 3D Printed Drugs Market by segment, 2018 & 2028 (USD Million)
• FIG 12. Global 3D Printed Drugs Market by segment, 2018 & 2028 (USD Million)
• FIG 13. Global 3D Printed Drugs Market by segment, 2018 & 2028 (USD Million)
• FIG 14. Global 3D Printed Drugs Market, regional snapshot 2018 & 2028
• FIG 15. North America 3D Printed Drugs Market2018 & 2028 (USD Million)
• FIG 16. Europe 3D Printed Drugs Market2018 & 2028 (USD Million)
• FIG 17. Asia Pacific 3D Printed Drugs Market2018 & 2028 (USD Million)
• FIG 18. Latin America 3D Printed Drugs Market2018 & 2028 (USD Million)
• FIG 19. Global 3D Printed Drugs Market, company market share analysis (2021)